{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:59:46Z","timestamp":1790369986702,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijrobp.2026.03.056","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:35:26Z","timestamp":1778877326000},"page":"687-695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Does Radiation Boost Dose Affect Organ Preservation Rates? A Secondary Analysis of the Organ Preservation in Patients With Rectal Adenocarcinoma Trial"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1268-8645","authenticated-orcid":false,"given":"Orly","family":"Yariv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyn A.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floris S.","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana M.","family":"Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina T.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.","family":"Gollub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard B.","family":"Saltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Garcia-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.03.056_bib0001","doi-asserted-by":"crossref","first-page":"806","DOI":"10.6004\/jnccn.2020.0032","article-title":"NCCN guidelines insights: Rectal cancer, version 6.2020","volume":"18","author":"Benson","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0002","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.0071","article-title":"Adoption of total neoadjuvant therapy for locally advanced rectal cancer","volume":"4","author":"Cercek","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0003","doi-asserted-by":"crossref","first-page":"e1555","DOI":"10.1002\/onco.13824","article-title":"Total neoadjuvant therapy (TNT) versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer: A systematic review and meta-analysis","volume":"26","author":"Liu","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0004","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): A randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0006","doi-asserted-by":"crossref","first-page":"513","DOI":"10.6004\/jnccn.2014.0056","article-title":"Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer","volume":"12","author":"Cercek","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0007","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/DCR.0000000000002290","article-title":"Total neoadjuvant therapy significantly increases complete clinical desponse","volume":"66","author":"Rettig","year":"2023","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0008","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): A multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0009","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1470-2045(15)00004-2","article-title":"Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: A multicentre, phase 2 trial","volume":"16","author":"Garcia-Aguilar","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0010","first-page":"106","article-title":"Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: Report of a multicenter randomized trial","volume":"14","author":"Chen","year":"2015","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0011","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.ejso.2018.05.003","article-title":"Bowel dysfunction after sigmoid resection underestimated: Multicentre study on quality of life after surgery for carcinoma of the rectum and sigmoid","volume":"44","author":"van Heinsbergen","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0012","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): An international multicentre registry study","volume":"391","author":"van der Valk","year":"2018","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0013","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/DCR.0000000000002122","article-title":"Organ preservation in patients with rectal cancer treated with total neoadjuvant therapy","volume":"64","author":"Jimenez-Rodriguez","year":"2021","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0014","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S2468-1253(17)30074-2","article-title":"A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: A systematic review and meta-analysis","volume":"2","author":"Dossa","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0015","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy","volume":"40","author":"Garcia-Aguilar","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0016","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijrobp.2007.12.019","article-title":"Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: Long-term analysis of 566 ypCR patients","volume":"72","author":"Capirci","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0017","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S1470-2045(15)00159-X","article-title":"Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO\/ARO\/AIO-04 study): Final results of the multicentre, open-label, randomised, phase 3 trial","volume":"16","author":"R\u00f6del","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0018","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1200\/JCO.2012.42.8771","article-title":"Clinical outcome of the ACCORD 12\/0405 PRODIGE 2 randomized trial in rectal cancer","volume":"30","author":"G\u00e9rard","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0019","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1200\/JCO.2013.53.7753","article-title":"Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: Surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04","volume":"32","author":"O'Connell","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1200\/JCO.20.01740","article-title":"Pre- and postoperative capecitabine without or with oxaliplatin in locally advanced rectal cancer: PETACC 6 trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD","volume":"39","author":"Schmoll","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0021","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijrobp.2012.05.017","article-title":"Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy","volume":"85","author":"Appelt","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0022","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.clon.2020.06.008","article-title":"Neoadjuvant radiotherapy dose escalation in locally advanced rectal cancer: A systematic review and meta-analysis of modern treatment approaches and outcomes","volume":"33","author":"Hearn","year":"2021","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0023","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1200\/JCO.23.01208","article-title":"Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: The randomized phase II OPRA trial","volume":"42","author":"Verheij","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0024","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ijrobp.2020.06.013","article-title":"Efficacy of dose-escalated chemoradiation on complete tumor response in patients with locally advanced rectal cancer (RECTAL-BOOST): A phase 2 randomized controlled trial","volume":"108","author":"Couwenberg","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0025","first-page":"e185","article-title":"Nonoperative rectal cancer management with short-course radiation followed by chemotherapy: A nonrandomized control trial","volume":"20","author":"Kim","year":"2021","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0026","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1186\/s12885-024-12529-7","volume":"24","author":"Alvarez","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0027","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/SLA.0000000000005507","article-title":"Intentional watch and wait or organ preservation surgery following neoadjuvant chemoradiotherapy plus consolidation CAPEOX for MRI-defined low-risk rectal cancer: Findings from a prospective phase 2 trial (PKUCH-R01 Trial, NCT02860234)","volume":"277","author":"Wang","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0028","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2468-1253(22)00392-2","article-title":"Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): A phase 3, randomised controlled trial","volume":"8","author":"Gerard","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0029","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.3390\/cancers14153665","article-title":"MORPHEUS phase II-III study: A pre-planned interim safety analysis and preliminary results","volume":"14","author":"Garant","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"17_suppl","key":"10.1016\/j.ijrobp.2026.03.056_bib0030","doi-asserted-by":"crossref","first-page":"LBA3514","DOI":"10.1200\/JCO.2022.40.17_suppl.LBA3514","article-title":"Curative chemoradiation for low rectal cancer: Primary clinical outcomes from a multicenter phase II trial","volume":"40","author":"Jensen","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0031","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ijrobp.2009.06.014","article-title":"A gene expression model of intrinsic tumor radiosensitivity: Prediction of response and prognosis after chemoradiation","volume":"75","author":"Eschrich","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.03.056_bib0032","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.2217\/fon-2020-0060","article-title":"Modeling precision genomic-based radiation dose response in rectal cancer","volume":"16","author":"Yuan","year":"2020","journal-title":"Future Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626005924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626005924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:08:38Z","timestamp":1790366918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626005924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0360301626005924"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.03.056","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does Radiation Boost Dose Affect Organ Preservation Rates? A Secondary Analysis of the Organ Preservation in Patients With Rectal Adenocarcinoma Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.03.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}